Gemina Laboratories Valuation
| GLABF Stock | USD 0.80 0.04 4.76% |
Today, the firm appears to be overvalued. Gemina Laboratories retains a regular Real Value of $0.61 per share. The prevalent price of the firm is $0.8. Our model calculates the value of Gemina Laboratories from evaluating the firm fundamentals such as Shares Outstanding of 64.1 M, return on equity of -3.47, and Return On Asset of -1.48 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that Gemina Laboratories' price fluctuation is out of control at this time. Calculation of the real value of Gemina Laboratories is based on 3 months time horizon. Increasing Gemina Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Gemina otc stock is determined by what a typical buyer is willing to pay for full or partial control of Gemina Laboratories. Since Gemina Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gemina OTC Stock. However, Gemina Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.8 | Real 0.61 | Hype 0.8 |
The real value of Gemina OTC Stock, also known as its intrinsic value, is the underlying worth of Gemina Laboratories OTC Stock, which is reflected in its stock price. It is based on Gemina Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Gemina Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Gemina Laboratories helps investors to forecast how Gemina otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gemina Laboratories more accurately as focusing exclusively on Gemina Laboratories' fundamentals will not take into account other important factors: Gemina Laboratories Total Value Analysis
Gemina Laboratories is currently forecasted to have takeover price of 17.22 M with market capitalization of 33.65 M, debt of 12.47 K, and cash on hands of 2.95 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Gemina Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.22 M | 33.65 M | 12.47 K | 2.95 M |
Gemina Laboratories Asset Utilization
One of the ways to look at asset utilization of Gemina is to check how much profit was generated for every dollar of assets it reports. Gemina Laboratories retains a negative application of resources of -1.48 (percent), losing $0.0148 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Gemina Laboratories shows how discouraging it operates for each dollar spent on its resources.Gemina Laboratories Ownership Allocation
Gemina Laboratories has a total of 64.1 Million outstanding shares. Gemina Laboratories secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Gemina Laboratories Profitability Analysis
Net Loss for the year was (4.73 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Gemina Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Gemina Laboratories and how it compares across the competition.
About Gemina Laboratories Valuation
The otc valuation mechanism determines Gemina Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Gemina Laboratories. We calculate exposure to Gemina Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Gemina Laboratories's related companies.Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.
8 Steps to conduct Gemina Laboratories' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Gemina Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Gemina Laboratories' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Gemina Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Gemina Laboratories' revenue streams: Identify Gemina Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Gemina Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Gemina Laboratories' growth potential: Evaluate Gemina Laboratories' management, business model, and growth potential.
- Determine Gemina Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Gemina Laboratories' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Gemina Laboratories Growth Indicators
Investing in growth stocks can be very risky. If the company such as Gemina Laboratories does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 55.6 M | |
| Retained Earnings | -5.6 M |
Complementary Tools for Gemina OTC Stock analysis
When running Gemina Laboratories' price analysis, check to measure Gemina Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gemina Laboratories is operating at the current time. Most of Gemina Laboratories' value examination focuses on studying past and present price action to predict the probability of Gemina Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gemina Laboratories' price. Additionally, you may evaluate how the addition of Gemina Laboratories to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |